| Line Item | 2023-07-31 | Y/Y |
|---|---|---|
| Revenue | $1.62B | +48.2% |
| Cost of Revenue | $362.8M | +49.8% |
| Gross Profit | $1.25B | +47.8% |
| R&D Expense | $349.7M | +21.0% |
| SG&A Expense | $177.5M | +17.0% |
| Operating Income | -$234.6M | +28.3% |
| Interest Expense | $6.5M | -88.4% |
| Pre-tax Income | -$182.6M | +52.4% |
| Income Tax | $19.8M |
| Line Item | 2023-07-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.26B | +24.6% |
| Accounts Receivable | $582.6M | +45.8% |
| Current Assets | $2.89B | +28.1% |
| Total Assets | $3.61B | +27.4% |
| Current Liabilities | $1.54B | +35.4% |
| Long-term Debt | $1.13B | +17.1% |
| Total Liabilities | $2.88B | +27.6% |
| Line Item | 2023-07-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $462.3M | +43.6% |
| Capital Expenditures | $97.2M | +40.3% |
| Investing Cash Flow | -$259.3M | -169.3% |
| Financing Cash Flow | $46.0M | +11.3% |
| Free Cash Flow | $365.1M | +44.5% |
| +197.4% |
| Net Income | -$202.3M | +48.2% |
| EPS (Basic) | -$1.40 | +49.5% |
| EPS (Diluted) | -$1.40 | +49.5% |
| Stockholders' Equity |
| $725.1M |
| +26.5% |